Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System
Clinical trial NCT00626314 · UNKNOWN
Trial details
- NCT number
- NCT00626314
- Sponsor
- Mytogen, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2010-03-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.